Symlin | ASweetLife

Insulin Pump Users Benefit from Symlin

New data from two previously completed clinical studies show that Symlin (pramlintide acetate) helped reduce A1c levels, insulin use and body weight in patients with type 1 diabetes who used insulin pumps. The data was presented by Amylin Pharmaceuticals during...

JDRF and Amylin Team Up to Investigate Hormone Combination for Diabetes Treatment

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide...

Symlin Does Not Increase Risk of Cardiovascular Event, New Study Shows

Amylin Pharmaceuticals, Inc. announced results from an analysis of an integrated database of clinical studies that showed no increased risk of cardiovascular (CV) events associated with SYMLIN(R) (pramlintide acetate) injection use compared to a pooled comparator group treated with either placebo or rapid-acting insulin...